What's in Dexa Medica Group's pipeline?

Dexa Medica Group has 14 drugs in our index: 1 marketed, 0 filed, 5 in Phase 3, 6 in Phase 2, 2 in Phase 1.

Which companies overlap with Dexa Medica Group's portfolio?

Top competitors by shared drug class: Başakşehir Çam & Sakura City Hospital, Fundação Educacional Serra dos Órgãos, Universidad de Antioquia.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/dexa-medica-group.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Dexa Medica Group — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexa Medica Group pipeline: 1 marketed, 0 filed, 5 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 5 Phase 3 6 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
placebo tablet of DLBS1033	placebo tablet of DLBS1033	marketed
Placebo of Reconyl	Placebo of Reconyl	phase 3
DLBS3233	DLBS3233	phase 3	Herbal extract / Natural product	Hepatology / Gastroenterology
Placebo capsule of DLBS3233	Placebo capsule of DLBS3233	phase 3
Placebo caplet of Metformin XR	Placebo caplet of Metformin XR	phase 3		Diabetes
Reconyl	Reconyl	phase 3		Other

Therapeutic area mix

Other · 2
Diabetes · 1
Gastroenterology · 1
Hepatology / Gastroenterology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Başakşehir Çam & Sakura City Hospital · 1 shared drug class
Fundação Educacional Serra dos Órgãos · 1 shared drug class
Universidad de Antioquia · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Dexa Medica Group:

Cite this brief

Drug Landscape (2026). Dexa Medica Group — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/dexa-medica-group. Accessed 2026-05-16.